No new treatments for schizophrenia have been approved in nearly three decades, but that changed on Sept. 26, when the U.S.

Bristol Myers Squibb Co. gained US approval for the first new type of schizophrenia drug in seven decades, opening a fresh ...

The U.S. Food and Drug Administration (FDA) on Thursday approved the first new drug to treat people with schizophrenia in ...

Doctors sometimes use lithium to treat schizophrenia. However, it is not a primary treatment method and evidence of its ...

And many patients who wind up with the label of bipolar disorder are initially misdiagnosed with unipolar depression. Misdiagnosed patients like Ola often look back on years of worsening symptoms and ...

A medicine that sidesteps the brain's dopamine receptors to reach different targets represents a new approach to ...

Explore hyposexuality in bipolar disorder, including symptoms like low libido, reduced sexual desire, and difficulty ...

Becoming a mother is a happy feeling, and only a mother can understand this feeling. But in today’s time, a woman often loses ...

The U.S. Food and Drug Administration (FDA) on Thursday approved the first new drug to treat people with schizophrenia in ...

With an FDA action date of Sept. 26, Bristol Myers Squibb’s KarXT could soon be the first new type of schizophrenia drug in ...

The Food and Drug Administration, as expected, approved KarXT, the first new type of drug for schizophrenia in decades. It appears to be effective, but its main advantage is milder side effects.

First Amendment: Congress shall make no law respecting an establishment of religion, or prohibiting the free exercise thereof; or abridging the freedom of speech, or of the press; or the right of the ...